Literature DB >> 6453137

Human platelet monoamine oxidase activity in health and disease: a review.

M Sandler, M A Reveley, V Glover.   

Abstract

The most readily available source of monoamine oxidase in man is the platelet, although only the B form of the enzyme is represented in this site. Platelet activity is higher in women than in men. The enzyme activity is generally stable and is partly under genetic control. There is some evidence that individuals with low activity have a higher psychiatric morbidity than those with high activity. Despite some negative studies, the consensus of publication dealing with schizophrenia, migraine, and alcoholism find that mean platelet monoamine oxidase activity in the patient group is lower than in the controls. Values are raised in unipolar depression. Technical differences, or patient or control group heterogeneity, might well account for the absence of unanimity in the literature. A considerable degree of overlap between patient and control values, whatever the clinical diagnosis, appears to be the standard finding. Apart from these neuropsychiatric disturbances, platelet monoamine oxidase activity is raised in megaloblastic anaemia and reduced in iron deficiency anaemia. Although altered enzyme activity values may be linked to abnormal platelet populations in some of the haematological disorders discussed, in general the causes of abnormal platelet monoamine oxidase activity are unknown.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6453137      PMCID: PMC1146480          DOI: 10.1136/jcp.34.3.292

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  123 in total

1.  Platelet monoamine oxidase activity in 116 normal rhesus monkeys: relations between enzyme activity and age, sex and genetic factors.

Authors:  D L Murphy; D E Redmond; J Baulu; C H Donnelly
Journal:  Comp Biochem Physiol C Comp Pharmacol       Date:  1978

2.  Schizophrenia in a North Swedish geographical isolate, 1900--1977. Epidemiology, genetics and biochemistry.

Authors:  J A Böök; L Wetterberg; K Modrzewska
Journal:  Clin Genet       Date:  1978-12       Impact factor: 4.438

3.  Platelet monoamine oxidase in affective disorders.

Authors:  D J Edwards; D G Spiker; D J Kupfer; G Foster; J F Neil; L Abrams
Journal:  Arch Gen Psychiatry       Date:  1978-12

4.  Decreased platelet monoamine oxidase activity in chronic schizophrenia, shown with novel substrates.

Authors:  W H Berrettini; W Prozialeck; W H Vogel
Journal:  Arch Gen Psychiatry       Date:  1978-05

Review 5.  Platelet monoamine oxidase activity in schizophrenia: a review of the data.

Authors:  R J Wyatt; S G Potkin; D L Murphy
Journal:  Am J Psychiatry       Date:  1979-04       Impact factor: 18.112

6.  Activities of types A and B MAO and catechol-o-methyltransferase in blood cells and skin fibroblasts of normal and chronic schizophrenic subjects.

Authors:  R Groshong; R J Baldessarini; D A Gibson; J F Lipinski; D Axelrod; A Pope
Journal:  Arch Gen Psychiatry       Date:  1978-10

7.  Platelet monoamine oxidase and serum dopamine-beta-hydroxylase activity in chronic alcoholics.

Authors:  J L Sullivan; C N Stanfield; S Schanberg; J Cavenar
Journal:  Arch Gen Psychiatry       Date:  1978-10

8.  Differences in platelet monoamine oxidase activity in subgroups of schizophrenic and depressive disorders.

Authors:  P J Orsulak; J J Schildkraut; A F Schatzberg; J M Herzog
Journal:  Biol Psychiatry       Date:  1978-12       Impact factor: 13.382

9.  Platelet monoamine oxidase activity in Huntington's chorea.

Authors:  J Mann; E Chiu
Journal:  J Neurol Neurosurg Psychiatry       Date:  1978-09       Impact factor: 10.154

10.  Migraine: A blood disorder?

Authors:  E Hanington
Journal:  Lancet       Date:  1978-09-02       Impact factor: 79.321

View more
  15 in total

Review 1.  Platelets: A possible glance into brain biological processes in schizophrenia.

Authors:  Eyal Asor; Dorit Ben-Shachar
Journal:  World J Psychiatry       Date:  2012-12-22

2.  Non-alcoholic fatty liver induces insulin resistance and metabolic disorders with development of brain damage and dysfunction.

Authors:  Doaa A Ghareeb; Hani S Hafez; Hend M Hussien; Nihal F Kabapy
Journal:  Metab Brain Dis       Date:  2011-09-01       Impact factor: 3.584

3.  Platelet monoamine oxidase B (MAO-B) activity and its relationship to DL-fenfluramine-induced prolactin response in healthy men.

Authors:  M Eriksson; U Berggren; C Fahlke; J Engel; J Balldin
Journal:  J Neural Transm (Vienna)       Date:  2005-06-15       Impact factor: 3.575

4.  Platelet monoamine oxidase activity and headache.

Authors:  V Glover; R Peatfield; R Zammit-Pace; J Littlewood; M Gawel; F C Rose; M Sandler
Journal:  J Neurol Neurosurg Psychiatry       Date:  1981-09       Impact factor: 10.154

Review 5.  Emerging Roles for Serotonin in Regulating Metabolism: New Implications for an Ancient Molecule.

Authors:  Julian M Yabut; Justin D Crane; Alexander E Green; Damien J Keating; Waliul I Khan; Gregory R Steinberg
Journal:  Endocr Rev       Date:  2019-08-01       Impact factor: 19.871

6.  Inhibition of monoamine oxidases by haloperidol and its metabolites: pharmacological implications for the chemotherapy of schizophrenia.

Authors:  J Fang; P H Yu; J W Gorrod; A A Boulton
Journal:  Psychopharmacology (Berl)       Date:  1995-03       Impact factor: 4.530

7.  Molecular properties of monoamine oxidases A and B.

Authors:  S W Kwan; J M Bergeron; C W Abell
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

8.  Platelet monoamine oxidase activity and schizophrenia--a myth that refuses to die?

Authors:  A Fleissner; R Seifert; K Schneider; W Eckert; B Fuisting
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1987

9.  No changes in lymphocyte muscarinic receptors and platelet monoamine oxidase-B examined as surrogate central nervous system biomarkers in a Faroese children cohort prenatally exposed to methylmercury and polychlorinated biphenyls.

Authors:  Teresa Coccini; Luigi Manzo; Frodi Debes; Ulrike Steuerwald; Pal Weihe; Philippe Grandjean
Journal:  Biomarkers       Date:  2009-03       Impact factor: 2.658

10.  beta-Carbolines as selective monoamine oxidase inhibitors: in vivo implications.

Authors:  V Glover; J Liebowitz; I Armando; M Sandler
Journal:  J Neural Transm       Date:  1982       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.